Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon W Moran

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Diagnostics (Basel, Switzerland)|November 27, 2021
Quantitative Magnetic Resonance Imaging in Perianal Crohn's Disease at 1.5 and 3.0 T: A Feasibility StudyAli Alyami, Caroline L Hoad, Christopher Tench, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Gut|June 23, 2025
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025Gordon W Moran, Morris Gordon, Vassiliki Sinopolou, et al.
Histopathology|January 17, 2024
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite studyAyesha S Azam, Yee-Wah Tsang, Jenny Thirlwall, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Diagnostics (Basel, Switzerland)|November 27, 2021
Quantitative Magnetic Resonance Imaging in Perianal Crohn's Disease at 1.5 and 3.0 T: A Feasibility StudyAli Alyami, Caroline L Hoad, Christopher Tench, et al.
The British Journal of Radiology|January 24, 2025
Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trialMaira Hameed, Stuart A Taylor, Norin Ahmed, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Insights Into Imaging|March 19, 2025
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's diseaseNaomi S Sakai, Andrew A Plumb, Norin Ahmed, et al.
BMJ Open Gastroenterology|February 9, 2024
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trialVipul Jairath, Guangyong Zou, Zhongya Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.
Gut|June 23, 2025
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025Gordon W Moran, Morris Gordon, Vassiliki Sinopolou, et al.
Histopathology|January 17, 2024
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite studyAyesha S Azam, Yee-Wah Tsang, Jenny Thirlwall, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 7